Journal
NEUROEPIDEMIOLOGY
Volume 26, Issue 1, Pages 30-36Publisher
KARGER
DOI: 10.1159/000089235
Keywords
blood pressure; cognition; Alzheimer disease; longitudinal studies; apolipoprotein E; antihypertensive agents
Funding
- NIA NIH HHS [R01 AG15819, P30 AG10161] Funding Source: Medline
- NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG015819] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Purpose: To examine the relation of systolic and diastolic blood pressure to incident Alzheimer's disease (AD) and rate of cognitive change. Methods: Longitudinal cohort study with annual clinical evaluations. At baseline, blood pressure was measured, apolipoprotein E (APOE) genotyping was performed, and medications were reviewed. Results: 824 older Catholic clergy members without baseline dementia were recruited from across the United States. During a mean of about 6 years of observation, 151 persons developed AD. In a proportional hazards model adjusted for age, sex and education, neither systolic (relative risk = 0.995; 95% CI: 0.986, 1.004, p = 0.249) nor diastolic (relative risk = 1.000; 95% CI: 0.985, 1.015, p = 0.975) blood pressure was related to AD incidence. In mixed effects models, neither systolic nor diastolic blood pressure was related to level or to annual rate of change on a global measure of cognition. These results did not change in subsequent models that accounted for the use of medications with antihypertensive properties or for the possession of an APOE epsilon 4 allele. Conclusions: In a cohort of older persons with a majority taking medications with antihypertensive properties, we did not find a relationship between blood pressure and risk of AD or cognitive decline. Copyright (C) 2006 S. Karger AG, Basel.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available